|
⚲
|
| Keyboard |
| James Connolly | |
|---|---|
| Firm | |
| Address | c/o Natomas Labs, Inc 1 Letterman Drive, C3500 San Francisco, CA 94129 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Natomas Labs Inc | 021-486366 | Executive Officer | 6.2 M of 18.0 M |
||
| Natomas Labs Inc | 021-468932 | Executive Officer | 29.0 M of 33.0 M |
||
| Vaxess Technologies Inc | 021-332963 | Director | 3.6 M of 3.6 M |
||
| Tivorsan Pharmaceuticals Inc | 021-324382 | Director | 1.6 M of 1.6 M |
||
| Tivorsan Pharmaceuticals Inc | 021-324378 | Director | 1.1 M of 1.1 M |
||
| Tivorsan Pharmaceuticals Inc | 021-324379 | Director | 2.8 M of 2.8 M |
||
| Tivorsan Pharmaceuticals Inc | 021-324385 | Director | 2.9 M of 2.9 M |
||
| Tivorsan Pharmaceuticals Inc | 021-324387 | Director | 4.5 M of 4.5 M |
||
| Tivorsan Pharmaceuticals Inc | 021-324388 | Director | 0.9 M of 1.0 M |
||
| Vaxess Technologies Inc | 021-277997 | Director | 0.9 M of 0.9 M |
||
| Paxvax Inc | 021-215901 | Director | 6.0 M of 15.0 M |
||
| Paxvax Inc | 021-208080 | Director | 34.9 M of 35.5 M |
||
| NBH Holdings Corp | 021-135854 | Executive Officer | 84.8 M of 84.8 M |
||